Wearable patches can be attached to the skin or can be worn for a few hours to a couple of weeks. These patches are becoming popular and can be used for drug delivery, patient monitoring, and diagnosing purpose. These patches are also been used for the treatment and delivery of medication such as nicotine patches in Nicotine Replacement Therapy (NRT) and anti-aging patches. The connected wearable patches feature wireless connectivity in addition to the feature of regular wearable patches that help in monitoring the health of an individual and delivering drugs accordingly. Features such as continuous monitoring of patients' body activity coupled with precise data, minimal interference with body movements, and easy connectivity with the various smartphones are some of the pivotal factors that are expected to drive the growth of the market.
Market Dynamics
Increasing adoption of organic growth strategies, such as product launches by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in May 2020, Philips, a health technology manufacturer, announced it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its wearable biosensor (Philips Biosensor BX100) to help manage confirmed and suspected COVID-19 patients in the hospital. The next-generation wireless wearable biosensor enhances clinical surveillance in the Philips patient deterioration detection solution to help clinicians detect risk so they can intervene earlier and help improve care for patients in lower acuity care areas.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook